Spacer Comparison In Adult Asthmatics

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Spacers are used by people with respiratory diseases who have problems using MDIs (metered dose inhalers). This study used fluticasone propionate/salmeterol to look at the pharmacokinetic profiles produced by different spacers in their washed and un-washed states.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Salmeterol Xinafoate; Xhance

Criteria

Inclusion criteria:

• Non-smoking with a BMI of 19 - 30

• Diagnosed with mild or intermittent asthma and taking medication for it.

Exclusion criteria:

• Taking oral corticosteroids or inhaled fluticasone propionate

• Have certain medical conditions or are not otherwise healthy.